Avalo Therapeutics (AVTX) Net Equity Issued and Repurchased (2016 - 2023)

Avalo Therapeutics' (AVTX) quarterly Net Equity Issued and Repurchased came in at $25.9 million in Q3 2023, up 70105305.41% on a QoQ basis from $37.0 in Q4 2020.

Avalo Therapeutics (AVTX) Net Equity Issued and Repurchased (2016 - 2023) Analysis & Trends

Avalo Therapeutics (AVTX) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $25.9 million in Q3 2023.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $25.9 million in Q3 2023, while the trailing twelve-month figure through Dec 2024 was $25.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $14.8 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased improved to $25.9 million in Q3 2023, from $37.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $35.4 million in Q2 2020 to a low of -$37.0 in Q3 2020.
  • A 3-year average of $14.1 million and a median of $9.0 million in 2019 frame the typical range for Net Equity Issued and Repurchased.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Avalo Therapeutics 854.16 Mn 453.89 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 25.94 Mn
Sep 30, 2023 25.94 Mn
Dec 31, 2020 37.00
Dec 31, 2020 37.00
Sep 30, 2020 -37.00
Sep 30, 2020 -37.00
Jun 30, 2020 35.43 Mn
Jun 30, 2020 35.43 Mn
Mar 31, 2019 8.98 Mn
Mar 31, 2019 8.98 Mn
Jun 30, 2017 506,934.00
Jun 30, 2017 506,934.00
Mar 31, 2017 1.19 Mn
Mar 31, 2017 1.19 Mn
Dec 31, 2016 900,000.00
Dec 31, 2016 900,000.00
Sep 30, 2016 900,000.00
Sep 30, 2016 900,000.00